Market reach Velos serves over 2,000 research sites across hospitals, health systems, and cancer centers, indicating a broad audience in clinical research that could benefit from upsell opportunities in CRMS features, regulatory workflows, and data quality modules.

Scale and adoption With more than 30,000 clinical studies and over half a million subject data points run through Velos eResearch, there is potential to position advanced analytics, data integration, and study lifecycle optimization to consolidate sites under a unified platform.

Sustainability potential Velos emphasizes improved patient care and cost reduction through its platform, suggesting cross-sell opportunities around value-based reporting, outcomes tracking, and operational dashboards to demonstrate ROI for research programs.

Market positioning Customers include 20 NCI-designated cancer centers and 38 academic medical centers, presenting a strong case for targeted collaborations with leading research institutions and expansion into oncology-focused modules and CTSA-aligned workflows.

Growth prompts Private, California-based vendor with a long-standing presence since 1996 indicates stability; consider strategic partnerships, channel partnerships, or joint offerings with larger CROs or health systems aiming to streamline clinical research operations.